![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/357 | (2006.01) |
A61K 31/42 | (2006.01) | ||
A61K 31/335 | (2006.01) | ||
A61K 31/4965 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/35 | (2006.01) | ||
A61K 31/39 | (2006.01) | ||
A61K 31/69 | (2006.01) | ||
A61K 38/55 | (2006.01) | ||
A61K 49/00 | (2006.01) | ||
G01N 33/50 | (2006.01) | ||
A61K 38/50 | (2006.01) | ||
A61K 31/422 | (2006.01) | ||
A61K 38/05 | (2006.01) |
(11) | Number of the document | 2491926 |
(13) | Kind of document | T |
(96) | European patent application number | 12150229.8 |
Date of filing the European patent application | 2006-03-22 | |
(97) | Date of publication of the European application | 2012-08-29 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
664470 P | 2005-03-22 | US |
(72) |
Anderson, Kenneth, C., US
Bradner, James, Elliott, US
Greenberg, Edward, Franklin, US
Hideshima, Teru, US
Kwiatkowski, Nicholas, Paul, US
Mazitschek, Ralph, US
Schreiber, Stuart, L., US
Shaw, Jared, US
Haggarty, Stephen, J, US
|
(73) |
President and Fellows of Harvard College,
17 Quincy Street, Cambridge, MA 02138,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US |
(54) | Treatment of protein degradation disorders |
Treatment of protein degradation disorders |